Nutraceuticals

BioHarvest Reports Third Quarter 2026 Results and Provides Business Update

Vancouver, British Columbia and Rehovot, Israel – November 12, 2026 - BioHarvest Sciences Inc (Nasdaq: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today reported financial results for the three and nine months ended September 30, 2026, and outlined its strategic priorities for 2027. The Company is aligning capital allocation, operating

BioHarvest Reports Third Quarter 2026 Results and Provides Business Update Read More »